Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of landiolol in the perioperative management of supraventricular tachycardia.

× No keyword cloud information.

8 in total

1. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting.

Authors: P R Kowey; J E Taylor; S J Rials; R A Marinchak
Journal: Am J Cardiol Date: 1992-04-01 Impact factor: 2.778

2. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.

Authors: A N Mooss; R L Wurdeman; S M Mohiuddin; A P Reyes; J T Sugimoto; W Scott; D E Hilleman; A Seyedroudbari
Journal: Am Heart J Date: 2000-07 Impact factor: 4.749

3. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.

Authors: J Sasao; S D Tarver; J D Kindscher; C Taneyama; K T Benson; H Goto
Journal: Can J Anaesth Date: 2001-11 Impact factor: 5.063

4. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.

Authors: H Atarashi; A Kuruma; M Yashima; H Saitoh; T Ino; Y Endoh; H Hayakawa
Journal: Clin Pharmacol Ther Date: 2000-08 Impact factor: 6.875

5. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

Authors: A Sugiyama; A Takahara; K Hashimoto
Journal: J Cardiovasc Pharmacol Date: 1999-07 Impact factor: 3.105

1 in total

1. Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.

Authors: Masahiro Osumi; Tadashi Tashiro; Yuichi Morita; Shinji Kamiya; Noritoshi Minematsu; Masaru Nishimi; Hideichi Wada
Journal: Adv Ther Date: 2014-10-16 Impact factor: 3.845

1 in total

Use of landiolol in the perioperative management of supraventricular tachycardia.

1. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting.

2. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.

3. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.

4. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.

5. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

6. Use of esmolol during anesthesia to treat tachycardia and hypertension.

7. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.

8. Hazards of postoperative atrial arrhythmias.

1. Preventive effect of intraoperative landiolol administration on atrial fibrillation after off-pump coronary artery bypass grafting.